Media Resources

2012

Big Pharma Spends Over €40 Million per Year Lobbying in the EU, Dwarfing Public Health NGOs

Civil Society Calls on Members of the European Parliament to Condemn ACTA

Divide and Conquer: A look behind the scenes of the EU pharmaceutical industry lobby

Business Conduct Guidelines

Complaints Procedure (EN)

Unlocking the Mysteries of Access to Clinical Trials Data in the EU

2011

Statement on Medicines Patent Pool

Universal Access to Medicines for Non-Communicable Diseases

Drop in Pay-for-Delay Good for Access to Medicines in Europe

Statement on Conflicts of Interests delivered at WHA

Statement on EU India and EU Mercosur Free-Trade Negotiations

Medicines pay-for-delay back under the microscope

2010

EU Citizens Get a Voice in Pharmacovigilance

Understanding & Responding to Pharmaceutical Promotion: A Practical Guide

2009

Unbiased medicines’ information: European best practices

Wyzwanie dla niezależnej informacji: dyrektywa w sprawie informowania pacjentów

Understanding and Responding to Pharmaceutical Promotion: A Practical Guide

The Tide is Turning Against Pharmaceutical Ads

Protect Legitimate Trade in Essential Medicines

HAI Requests Government Documents on Generic Medicines Seizures

Release of Generic ARV Medicines by Dutch Customs Authorities

2007

HAI Constitution

2006

Fast, Furious, and Flexible

2005

East Africa Community and a 10% Tax on Medicines